Unknown

Dataset Information

Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations.


ABSTRACT:

Background

There are contradictory reports regarding the effects of protease inhibitors on the ECG measures of QT and PR interval durations. The effect of interrupting use of protease inhibitors on QT and PR progression is also unknown.

Methods

This analysis included 3719 participants from the Strategies for Management of Antiretroviral Therapy (SMART) study, of whom 1879 were randomized to receive intermittent antiretroviral therapy (ART) (drug conservation group), whereas the rest received these drugs continuously (viral suppression group). Linear regression analysis was used to compare four ritonavir-boosted protease inhibitor (protease inhibitor/r) regimens [saquinavir (SQV/r), lopinavir (LPV/r), atazanavir (ATV/r), and other protease inhibitor/r], and nonboosted proteas

SUBMITTER: Soliman EZ 

PROVIDER: S-EPMC3111078 | biostudies-literature | 2011 Jan

REPOSITORIES: biostudies-literature